Catherine Alix-Panabières

About Catherine Alix-Panabières

Catherine Alix-Panabières, With an exceptional h-index of 58 and a recent h-index of 46 (since 2020), a distinguished researcher at Université de Montpellier, specializes in the field of Biologie des Tumeurs, Cellules Tumorales Circulantes, Dissémination tumorale.

His recent articles reflect a diverse array of research interests and contributions to the field:

Overall survival with circulating tumor cell count–driven choice of therapy in advanced breast cancer: A randomized trial

Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell …

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Cancer: Biology and Diagnostics

Circulating tumor cells: from basic to translational research

First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof‐of‐concept study

Circulating tumor DNA clinical applications in hepatocellular carcinoma: current trends and future perspectives

Cost-effectiveness of CTC guided chemo-or endocrine therapy in ER+ HER2-metastatic breast cancer–results from a randomized controlled multicenter trial

Catherine Alix-Panabières Information

University

Position

Biologie Cellulaire

Citations(all)

16517

Citations(since 2020)

9258

Cited By

10778

hIndex(all)

58

hIndex(since 2020)

46

i10Index(all)

113

i10Index(since 2020)

104

Email

University Profile Page

Google Scholar

Catherine Alix-Panabières Skills & Research Interests

Biologie des Tumeurs

Cellules Tumorales Circulantes

Dissémination tumorale

Top articles of Catherine Alix-Panabières

Overall survival with circulating tumor cell count–driven choice of therapy in advanced breast cancer: A randomized trial

Journal of Clinical Oncology

2024/2/1

Luis Teixeira
Luis Teixeira

H-Index: 3

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell …

British Journal of Cancer

2024/1/31

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis

Healthcare

2024/1/19

Cancer: Biology and Diagnostics

2024/1

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Circulating tumor cells: from basic to translational research

2024/1

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof‐of‐concept study

Cancer Medicine

2024/1

Circulating tumor DNA clinical applications in hepatocellular carcinoma: current trends and future perspectives

2024/1

Thomas Bardol
Thomas Bardol

H-Index: 1

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Cost-effectiveness of CTC guided chemo-or endocrine therapy in ER+ HER2-metastatic breast cancer–results from a randomized controlled multicenter trial

2023/10/9

Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer

Scientific Reports

2023/10/9

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

237TiP GUIDE. MRD: a Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA …

Annals of Oncology

2023/10/1

Precision cancer medicine: Concepts, current practice, and future developments

2023/10

Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer

Scientific Reports

2023/9/16

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood

Frontiers in cell and developmental biology

2023/8/2

Danijela Koppers-Lalic
Danijela Koppers-Lalic

H-Index: 16

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology

Cells

2023/7/26

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

The effect of placentation type, litter size, lactation and gestation length on cancer risk in mammals

Proceedings of the Royal Society B

2023/6/28

Orsolya Vincze
Orsolya Vincze

H-Index: 9

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Beata Ujvari
Beata Ujvari

H-Index: 26

Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype

2023/5/5

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer

Journal of Personalized Medicine

2023/3/30

Michał Nowicki
Michał Nowicki

H-Index: 10

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Abstract GS3-09: GS3-09 Circulating Tumor Cells-driven choice of first line therapy for ER+ HER2-metastatic breast cancer: overall survival analysis of the randomized STIC CTC …

Cancer Research

2023/3/1

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Luis Teixeira
Luis Teixeira

H-Index: 3

Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial Cancer Surgery: A Pilot Study

Biomolecules

2023/2/24

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

Abstract IA008: Biology of metastasis-competent circulating tumor cells

Cancer Research

2023/1/15

Catherine Alix-Panabières
Catherine Alix-Panabières

H-Index: 38

See List of Professors in Catherine Alix-Panabières University(Université de Montpellier)

Co-Authors

academic-engine